Subscribe to RSS
DOI: 10.1055/s-2007-990246
© Georg Thieme Verlag KG Stuttgart · New York
Large Conductance Ca2+-Activated K+ (BKCa) Channels are Involved in the Vascular Relaxations Elicited by Piceatannol Isolated from Rheum undulatum rhizome
Publication History
Received: July 27, 2007
Revised: September 19, 2007
Accepted: September 21, 2007
Publication Date:
24 October 2007 (online)
Abstract
We previously reported that piceatannol isolated from the rhizome extract of Rheum undulatum has a potent vasorelaxant activity. In the present study, the mechanisms underlying the direct vascular relaxant effect of piceatannol were investigated in isolated rat aorta. Piceatannol induced a concentration-dependent relaxation in aortic preparations precontracted with phenylephrine (EC50 : 2.4 ± 0.4 μM), which was completely inhibited by endothelial removal, N ω-nitro-L-arginine (nitric oxide synthase inhibitor), methylene blue and 1H-[1] [2] [4]oxadiazolo [4,3-a]quinoxalin-1-one (guanylyl cyclase inhibitor). The piceatannol-induced relaxation was also blocked by raising the extracellular K+ (45 mM), 4-aminopyridine (voltage-sensitive K+ channel blocker) and tetraethylammonium [the non-selective Ca2+-activated K+ (KCa) channel blocker] but not by indomethacin (cyclooxygenase inhibitor), atropine (muscarinic receptor antagonist), propranolol (β-adrenoceptor antagonist), verapamil and nifedipine (L-type voltage-gated Ca2+ channel blocker), barium chloride (inward rectifier K+ channel inhibitor) and glibenclamide (ATP-sensitive K+ channel blocker). In further studies investigating the role of Ca2+-activated K+ (KCa) channels, piceatannol-induced relaxant responses were decreased by charybdotoxin [large (BKCa)- and intermediate (IKCa)-conductance KCa channel blocker], iberiotoxin (selective BKCa channels blocker), but not by apamin [small-conductance KCa (SKCa) channel blocker], TRAM-34 [intermediate-conductance KCa (IKCa) channel blocker]. The present results demonstrate that piceatannol-induced vascular relaxation in rat aorta may be mediated by an endothelium-dependent nitric oxide signaling pathway, at least partially, through the activation of BKCa.
Abbreviations
BKCa channel: large conductance KCa channel
IKCa channel: intermediate conductance KCa channel
KATP channel: ATP-sensitive K+ channel
KCa channel: Ca2+-activated K+ channel
KIR channel: inward rectifier K+ channel
Kv channel: voltage-dependent K+ channel
L-NNA: N ω-nitro-L-arginine
MB: methylene blue
ODQ: 1H-[1] [2] [4] oxadiazolo[4,3-a]quinoxalin-1-one
SKCa channel: small conductance KCa channel
TEA: tetraethylammonium
TRAM 34: 1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole
Key words
Rheum undulatum - Polygonaceae - piceatannol - vasorelaxation - Ca2+-activated K+ channel - BKCa channels - rat aorta
References
- 1 Curin Y, Andriantsitohaina R. Polyphenols as potential therapeutical agents against cardiovascular diseases. Pharmacol Rep. 2005; 57 97-107.
- 2 Pechanova O, Rezzani R, Babal P, Bernatova I, Andriantsitohaina R. Beneficial effects of provinols: cardiovascular system and kidney. Physiol Res. 2006; 55 S17-30.
- 3 Wu J M, Wang Z R, Hsieh T C, Bruder J L, Zou J G, Huang Y Z. Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine. Int J Mol Med. 2001; 8 3-17.
- 4 Ferrigni N R, McLaughlin J L, Powell R G, SmithCR J r. Use of potato disc and brine shrimp bioassays to detect activity and isolate piceatannol as the antileukemic principle from the seeds of Euphorbia lagascae . J Nat Prod. 1984; 47 347-52.
- 5 Wieder T, Prokop A, Bagci B, Essmann F, Bernicke D, Schulze-Osthoff K. et al . Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblasts. Leukemia. 2001; 15 1735-42.
- 6 Geahlen R L, McLaughlin J L. Piceatannol (3,4,3′,5′-tetrahydroxy-trans-stilbene) is a naturally occurring protein-tyrosine kinase inhibitor. Biochem Biophys Res Commun. 1989; 165 241-5.
- 7 Matsuda H, Kageura T, Morikawa T, Toguchida I, Harima S, Yoshikawa M. Effects of stilbene constituents from rhubarb on nitric oxide production in lipopolysaccharide-activated macrophages. Bioorg Med Chem Lett. 2000; 10 323-7.
- 8 Ashikawa K, Majumdar S, Banerjee S, Bharti A C, Shishodia S, Aggarwal B B. Piceatannol inhibits TNF-induced NF-kappaB activation and NF-kappaB-mediated gene expression through suppression of IkappaB alpha kinase and p65 phosphorylation. J Immunol. 2002; 169 6490-7.
- 9 Moon M K, Kang D G, Lee J K, Kim J S, Lee H S. Vasodilatory and anti-imflammatory effects of the aqueous extract of rhubarb via a NO-cGMP pathway. Life Sci. 2006; 78 1550-7.
- 10 Yoo M Y, Oh K S, Lee J W, Seo H W, Yon G H, Kwon D Y. et al . Vasorelaxation effect of stilbenes from rhizome extract of rhubarb (Rheum undulatum) on the contractility of rat aorta. Phytother Res. 2007; 21 186-9.
- 11 Lee B H, Lee C O, Kwon M J, Yi K Y, Yoo S E, Choi S U. Differential effects of the optical isomers of KR30031 on cardiotoxicity and on multidrug resistance reversal activity. Anticancer Drugs. 2003; 14 175-81.
- 12 Rapoport R M, Draznin M B, Murad F. Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation. Nature. 1983; 306 174-6.
- 13 Olson L J, Knych ET J r, Herzig T C, Crewett J G. Selective guanylyl cyclase inhibitor reverses nitric oxide-induced vasorelaxation. Hypertension. 1997; 29 254-61.
- 14 Abebe W, Maddux W F. Roles of nitric oxide and prostacyclin in triethyleneglycol dimethacrylate (TEGDMA)-induced vasorelaxation. . 2006; 22 37-44.
- 15 Kang D G, Yin M H, Oh H, Lee D H, Lee H S. Vasorelaxation by amentoflavone isolated from Selaginella tamariscina . Planta Med. 2004; 70 718-22.
- 16 Wang G J, Wu X C, Chen C F, Lin L C, Huang Y T, Shan J. et al . Vasorelaxing action of rutaecarpine: effects of rutaecarpine on calcium channel activities in vascular endothelial and smooth muscle cells. J Pharmacol Exp Ther. 1999; 289 1237-44.
- 17 Pirotton S, Raspe E, Demolle D, Erneux C, Boeynaems J M. Involvement of inositol 1,4,5-triphosphate and calcium in the action of adenosine nucleotides on aortic endothelial cells. J Biol Chem. 1987; 262 17 461-6.
- 18 Kuhberger E, Kukovetz W R, Groschner K. Cromakalim inhibits multiple mechanisms of smooth muscle activation with similar stereoselectivity. J Cardiovasc Pharmacol. 1993; 21 947-54.
- 19 Edwards G, Dora K A, Gardener M J, Garland C J, Weston A H. K+ is an endothelium-derived hyperpolarizing factor in rat arteries. Nature. 1998; 396 269-72.
- 20 Knot H J, Zimmermann P A, Nelson M T. Extracellular K(+)-induced hyperpolarizations and dilatations of rat coronary and cerebral arteries involve inward rectifier K(+) channels. J Physiol. 1996; 492 419-30.
- 21 Awe S O, Adeagbo A S, D'Souza S E, Bhatnagar A, Conklin D J. Acrolein induces vasodilatation of rodent mesenteric bed via an EDHF-dependent mechanism. Toxicol Appl Pharmacol. 2006; 217 266-76.
- 22 Standen N B, Quayle J M, Davies N W, Brayden J E, Huang Y, Nelson M T. Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle. Science. 1989; 245 77-80.
- 23 Chrissobolis S, Sobey C G. Inwardly rectifying potassium channels in the regulation of vascular tone. Curr Drug Targets. 2003; 4 281-9.
- 24 Li N F, Chen S A, Wu S N. Evidence for the stimulatory effect of resveratrol on Ca(2+)-activated K+ current in vascular endothelial cells. Cardiovasc Res. 2000; 45 1035-45.
- 25 Calderone V, Martelli A, Testai L, Martinotti E, Breschi M C. Functional contribution of the endothelial component to the vasorelaxing effect of resveratrol and NS 1619, activators of the large-conductance calcium-activated potassium channels. Naunyn Schmiedebergs Arch Pharmacol. 2007; 375 73-80.
- 26 Edwards G, Niederste-Hollenberg A, Schneider J, Noack T, Weston A H. Ion channel modulation by NS 1619, the putative BKCa channel opener, in vascular smooth muscle. Br J Pharmacol. 1994; 113 1538-47.
- 27 Chen S J, Wu C C, Yang S N, Lin C I, Yen M G. Abnormal activation of K(+) channels in aortic smooth muscle of rats with endotoxic shock: electrophysiological and functional evidence. Br J Pharmacol. 2000; 131 213-22.
Byung Ho Lee, PhD
Drug Discovery Division
Korea Research Institute of Chemical Technology
100 Jang-dong
Yuseong
Daejeon 305-343
Republic of Korea
Phone: +82-42-860-7415
Fax: +82-42-861-4246
Email: bhlee@krict.re.kr